Loading
NASDAQHealthcareMedical - Healthcare Information Services
Latest quote
$49.88
+$4.39 · +9.65%
HeartFlow, Inc. operates as a global medical technology firm, specializing in providing non-surgical solutions for the diagnosis and ongoing management of coronary artery disease. Its innovative HeartFlow Platform employs artificial intelligence and advanced computational fluid dynamics to generate a unique, three-dimensional digital replica of a patient's heart. This intricate model is created from a single coronary computed tomography angiography (CCTA), which is a specialized scan designed to produce highly detailed images of the heart's arterial network. The platform offers vital insights into aspects like blood flow, the extent of arterial narrowing (stenosis), and the volume and composition of any plaque present, thereby overcoming the limitations typically associated with traditional non-invasive imaging techniques. Founded in 2007, the company is headquartered in Mountain View, California.
Previous close
$49.88
+$4.39 · +9.65%
Regular session · ET · Market data may be delayed.
HeartFlow, Inc. operates as a global medical technology firm, specializing in providing non-surgical solutions for the diagnosis and ongoing management of coronary artery disease. Its innovative HeartFlow Platform employs artificial intelligence and advanced computational fluid dynamics to generate a unique, three-dimensional digital replica of a patient's heart. This intricate model is created from a single coronary computed tomography angiography (CCTA), which is a specialized scan designed to produce highly detailed images of the heart's arterial network. The platform offers vital insights into aspects like blood flow, the extent of arterial narrowing (stenosis), and the volume and composition of any plaque present, thereby overcoming the limitations typically associated with traditional non-invasive imaging techniques. Founded in 2007, the company is headquartered in Mountain View, California.
Day range
Current $49.88
52-week range
Current $49.88
Regular session · ET · Market data may be delayed.
GoAI Score
Hold
Valuation
64
Undervalued
Sentiment
56
Mixed
Risk
66
High Risk
Momentum
29
Weakening
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
HeartFlow, Inc. operates as a global medical technology firm, specializing in providing non-surgical solutions for the diagnosis and ongoing management of coronary artery disease. Its innovative HeartFlow Platform employs artificial intelligence and advanced computational fluid dynamics to generate a unique, three-dimensional digital replica of a patient's heart. This intricate model is created from a single coronary computed tomography angiography (CCTA), which is a specialized scan designed to produce highly detailed images of the heart's arterial network. The platform offers vital insights into aspects like blood flow, the extent of arterial narrowing (stenosis), and the volume and composition of any plaque present, thereby overcoming the limitations typically associated with traditional non-invasive imaging techniques. Founded in 2007, the company is headquartered in Mountain View, California.
Day range
Current $49.88
52-week range
Current $49.88
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | 176.03M USD | 125.81M USD | 87.17M USD |
| Cost of goods sold | 40.84M USD | 31.36M USD | 29.12M USD |
| Gross profit | 135.2M USD | 94.45M USD | 58.05M USD |
| Research and development | 64.92M USD | 43.52M USD | 35.85M USD |
| Selling, general, and administrative | 134.35M USD | 112.15M USD | 95.11M USD |
| Operating expenses | 199.26M USD | 155.67M USD | 130.97M USD |
| Interest income | 5.54M USD | 4.07M USD | 5.46M USD |
| Interest expense | 15.17M USD | 22.77M USD | 24.69M USD |
| Depreciation and amortization | 8.57M USD | 8.14M USD | 7.59M USD |
| Operating income | −64.07M USD | −61.22M USD | −72.91M USD |
| Net income | −116.79M USD | −96.43M USD | −95.66M USD |
Company facts updated Sep 12, 2026.
Recent quarterly results
Recent quarterly results
Third-party consensus; not a GoAI recommendation.
Average target
$44.57
10.65% downsideFunds reporting this stock among their holdings, ordered by reported position size.
iShares Russell 2000 ETFIWM95.3M0.12%77.55B USD0.19%$288.89+0.41%
Vanguard Morningstar Total Stock Market ETFVTI62.52M0.00%2.3T USD0.03%$376.31+0.82%
Vanguard Morningstar Small-Cap ETFVB45.04M0.02%183.4B USD0.03%$293.45+0.78%
iShares Russell 2000 Growth ETFIWO35.25M0.24%14.32B USD0.24%$367.63+0.54%
Vanguard Morningstar Small-Cap Value ETFVBR28.59M0.04%68.3B USD0.05%$242.1+0.77%
Vanguard Russell 2000 ETFVTWO11.38M0.06%17.4B USD0.06%$116.76+0.36%
Vanguard Extended Market ETFVXF5.23M0.01%93.7B USD0.05%$237.76+0.68%
Schwab U.S. Small-Cap ETFSCHA3.96M0.02%22.32B USD0.03%$33.79+0.42%iShares Russell 2000 ETFIWMVanguard Morningstar Total Stock Market ETFVTIVanguard Morningstar Small-Cap ETFVBiShares Russell 2000 Growth ETFIWOVanguard Morningstar Small-Cap Value ETFVBRVanguard Russell 2000 ETFVTWOVanguard Extended Market ETFVXFSchwab U.S. Small-Cap ETFSCHAAI-generated and delayed market data for informational and educational purposes only. Not investment advice.
